A molecular cytogenetic approach to studying platinum resistance

Journal of Inorganic Biochemistry

Volumn 77, Issue 1-2, 1999, Pages 95-104

  Hiorns, L R ^a   Seckl, M J ^b   Paradinas, F ^c   Sharp, S Y ^c   Skelton, L A ^c   Brunstrom, G ^b   Newlands, E S ^b   Kelland, L R ^c   Leyland Jones, B ^d  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Biopsy samples; Cell lines; CGH, testicular germ cell tumours; Molecular cytogenetics; Platinum resistance

Indexed keywords

4 [N (7 BROMO 3,4 DIHYDRO 2 METHYL 4 OXO 6 QUINAZOLINYLMETHYL) N (2 PROPYNYL)AMINO] N (3 PYRIDYLMETHYL)BENZAMIDE; AMMINEDICHLORO(2 METHYLPYRIDINE)PLATINUM; CISPLATIN; CYTOTOXIC AGENT; PLATINUM; SATRAPLATIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CHROMOSOME 12P; CHROMOSOME 13Q; CHROMOSOME 18Q; CHROMOSOME 2Q; CHROMOSOME 4P; CHROMOSOME 4Q; CHROMOSOME 5Q; CHROMOSOME 6Q; CHROMOSOME 7Q; CHROMOSOME 8Q; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; DRUG RESISTANCE; DRUG STRUCTURE; GENETIC ANALYSIS; GERM CELL TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; X CHROMOSOME;

ANTINEOPLASTIC AGENTS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; CISPLATIN; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; HUMANS; IN SITU HYBRIDIZATION; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; ORGANOPLATINUM COMPOUNDS; PLATINUM COMPOUNDS; QUINAZOLINES; TESTICULAR NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0033378444     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(99)00140-3     Document Type: Article

References (49)

1. E. Reed, in: V.T. DeVita, S. Hellman, S.A. Rosenberg (Eds.), Cancer Principles and Practice of Oncology, J.B. Lippincott, Philadelphia, 1993, p. 390.
2. Kallioniemi A., Kallioniemi O.P., Sudar D., Rutovitz D., Gray J.W., Waldman F., Pinkel D. Science. 258:1992;818-821.
3. L.R. Hiorns, in: G.J. Swansbury (Ed.), Comparative Genomic Hybridisation. Cytogenetic Methods and Protocols: Methods in Molecular Biology, Humana, Clifton, NJ, 1999, in press.
4. Kirchhoff M., Gerdes T., Maahr J., Rose H., Lundsteen C. Cytometry. 28:1997;130-134.
5. Leyland-Jones B., Kelland L.R., Harrap K.R., Hiorns L.R. Am. J. Pathol. 155:1999;1793-1799.
6. Kallioniemi A., Kallioniemi O.-P., Piper J., Tanner M., Stokke T., Chen L., Smith H.S., Pinkel D., Gray J.W., Waldman F.M. Proc. Natl. Acad. Sci. USA. 91:1994;2156-2160.
7. Kallioniemi A., Kallioniemi O.P., Citro G., Sauter G., De-Vries S., Kerschmann R., Caroll P., Waldman F. Genes Chromosomes Cancer. 12:1995;213-219.
8. Visakorpi T., Kallioniemi A.H., Syvanen A.C., Hyytinen E.R., Karhu R., Tammela T., Isola J.J., Kallioniemi O.P. Cancer Res. 55:1995;342-347.
9. Bentz M., Dohner H., Huck K., Schutz B., Ganser A., Joos S., du-Manoir S., Lichter P. Genes Chromosomes Cancer. 12:1995;193-200.
10. Bentz M., Huck K., du-Manoir S., Joos S., Werner C.A., Fischer K., Dohner H., Lichter P. Blood. 12:1995;3610-3618.
11. Houldsworth J., Mathew S., Rao P.H., Dyomina K., Louie D.C., Parsa N., Offit K., Chaganti R.S. Blood. 87:1996;25-29.
12. Tanner M.M., Tirkkonen M., Kallioniemi A., Collins C., Stokke T., Karhu R., Kowbel D., Shadravan F., Hintz M., Kuo W.-L., Waldman F.M., Isola J.J., Gray J.W., Kallioniemi O.-P. Cancer Res. 54:1994;4257-4260.
13. Schabel F.M., Trader M.W., Laster W.R., Wheeler G.P., Witt M.H. Antibiot. Chemother. 23:1978;200-215.
14. Hoare S.F., Freeman C.A., Coutts J.C., Varley J.M., James L., Keith W.N. Br. J. Cancer. 75:1997;275-282.
15. Wasenius V.M., Jekunen A., Monni O., Joensuu H., Aebi S., Howell S.B., Knuutila S. Genes Chromosomes Cancer. 18:1997;286-291.
16. Kobayashi H., Takemura Y., Miyachi H., Skelton L., Jackman A.L. Jpn. J. Cancer Res. 86:1995;1014-1018.
17. Skelton L.A., Ormerod M.G., Titley J., Kimbell R., Brunton L.A., Jackman A.L. Br. J. Cancer. 79:1999;1692-1701.
18. Skelton L.A., Coignet L.J.A., Hiorns J.R., Jackman A.L. Proc. AACR. 40:1999;426.
19. Rosenberg B., VanCamp L., Trosko J.E., Mansour V.H. Nature. 222:1969;385-386.
20. O'Neill C.F., Orr R.M., Kelland L.R., Harrap K.R. Cell. Pharmacol. 2:1995;1-7.
21. Loh S.Y., Mistry P., Kelland L.R., Abel G., Harrap K.R. Br. J. Cancer. 66:1992;1109-1115.
22. Kelland L.R., Mistry P., Abel G., Loh S.Y., O'Neill C.F., Murrer B.A., Harrap K.R. Cancer Res. 52:1992;3857-3864.
23. Mellish K.J., Kelland L.R. Cancer Res. 54:1994;4118-4122.
24. J. Holford, Thesis, University of London, 1997, pp. 142-158.
25. Holford J., Sharp S.Y., Murrer B.A., Abrams M., Kelland L.R. Br. J. Cancer. 77:1998;366-373.
26. Scanlon K.J., Kashani-Sabet M., Sowers L.C. Cancer Commun. 1:1989;269-275.
27. Drummond J.T., Anthoney A., Brown R., Modrich P. J. Biol. Chem. 271:1996;19645-19648.
28. Hasegawa S., Naito S., Kotoh S., Koga H., Yokomizo A., Yamasaki T., Noma H., Kumuzawa J. Nishinihon J. Urol. 58:1996;331-336.
29. Leegte B., vanEchten J., van-derVeen A.Y., Withoff S., Timmer-Bosscha H., deVries E.G., deJong B. Proc. Annu. Meet. Am. Assoc. Cancer Res. 37:1996;3806a.
30. Christen R.D., Hom D.K., Porter D.C., Andrews P.A., MacLeod C.L., Hafstrom L., Howell S.B. J. Clin. Invest. 86:1990;1632-1640.
31. Billings P.C., Davis R.J., Engelsberg B.N., Skov K.A., Hughes E.N. Biochem. Biophys. Res. Commun. 188:1992;1286-1294.
32. McClay E.F., Albright K.D., Jones J.A., Eastman A., Christen R., Howell S.B. Cancer Res. 52:1992;6790-6796.
33. Perego P., Giarola M., Righetti S.C., Supino R., Caserini C., Delia D., Pierotti M.A., Miyashita T., Reed J.C., Zunino F. Cancer Res. 56:1996;556-562.
34. Fajac A., DaSilva J., Ahomadegbe J.C., Ratear J.G., Bernaudin J.F., Riou G., Benard J. Proc. Annu. Meet. Am. Assoc. Cancer Res. 37:1996;2814a.
35. Funato T., Yoshida E., Jiao L., Tone T., Kashani-Sabet M., Scanlon K.J. Adv. Enzyme Regul. 32:1992;195-209.
36. Kikuchi Y., Iwano I., Miyauchi M., Sasa H., Nagata I., Kuki E. Gynecol. Oncol. 39:1990;199-203.
37. Wu L., Wu A., Jiang K. Chung Hua Fu Chan Ko Tsa Chih. 31:1996;169-172.
38. Tsai C.-M., Chang K.-T., Perng R.-P., Mitsudomi T., Chen M.-H., Kadoyama C., Gazdar A.F. J. Natl. Cancer Inst. 85:1993;897-901.
39. Rubin E., Kharbanda S., Gunji H., Weichselbaum R., Kufe D. Cancer Res. 52:1992;878-882.
40. Basu A., Teicher B.A., Lazo J.S. J. Biol. Chem. 265:1990;8451-8457.
41. Eliopoulos A.G., Kerr D.J., Herod J., Hodgkins L., Krajewski S., Reed J.C., Young L.S. Oncogene. 11:1995;1217-1228.
42. Taniguchi K., Wada M., Kohno K., Nakamura T., Kawabe T., Kawakami M., Kagotani K., Okumura K., Akiyama S.I., Kuwano M. Cancer Res. 56:1996;4124-4129.
43. Corbett T., Valeriote F., LoRusso P., Polin L., Panchapor C., Pugh S., White K., Knight J., Demchik L., Jones J., Jones L., Lowichik N., Biernat L., Foster B., Wozniak A., Lisow L., Valdivieso M., Baker L., Leopold W. Int. J. Pharmacogn. (Suppl.). 33:1995;102-122.
44. Speth P.A., Kinsella T.J., Chang A.E., Klecker Jr R.W., Belanger K., Smith R., Rowland J., Cupp J.E., Collins J.M. Int. J. Radiat. Oncol. Biol. Phys. 16:1989;1247-1250.
45. E. Liu, personal communication, 1997.
46. Telenius H., Carter N.P., Bebb C.E., Nordenskjold M., Ponder B.A.J., Tunnacliffe A. Genomics. 13:1992;718-725.
47. Bower M., Newlands E.S., Holden L., Rustin G.J., Begent R.H. Ann. Oncol. 8:1997;477-483.
48. Mostert M.M., Van-de-Pol M., Olde-Weghuis D., Suijkerbuijk R.F., Guerts-van-Kessel A., Van-Echten J., Oosterhuis J.W., Looijenga L.H. Cancer Genet. Cytogenet. 89:1996;146-152.
49. Summersgill B., Goker H., Weber-Hall S., Huddart R., Horwich A., Shipley J. Br. J. Cancer. 77:1998;305-313.